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On the Genetic Interpretation of Disease Data
Stephen C. Bishop*, John A. Woolliams
The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin, Midlothian, United Kingdom
Abstract
Background: The understanding of host genetic variation in disease resistance increasingly requires the use of field data to
obtain sufficient numbers of phenotypes. We introduce concepts necessary for a genetic interpretation of field disease data,
for diseases caused by microparasites such as bacteria or viruses. Our focus is on variance component estimation and we
introduce epidemiological concepts to quantitative genetics.
Methodology/Principal Findings: We have derived simple deterministic formulae to predict the impacts of incomplete
exposure to infection, or imperfect diagnostic test sensitivity and specificity on heritabilities for disease resistance. We show
that these factors all reduce the estimable heritabilities. The impacts of incomplete exposure depend on disease prevalence
but are relatively linear with the exposure probability. For prevalences less than 0.5, imperfect diagnostic test sensitivity
results in a small underestimation of heritability, whereas imperfect specificity leads to a much greater underestimation,
with the impact increasing as prevalence declines. These impacts are reversed for prevalences greater than 0.5. Incomplete
data recording in which infected or diseased individuals are not observed, e.g. data recording for too short a period, has
impacts analogous to imperfect sensitivity.
Conclusions/Significance: These results help to explain the often low disease resistance heritabilities observed under
field conditions. They also demonstrate that incomplete exposure to infection, or suboptimal diagnoses, are not fatal
flaws for demonstrating host genetic differences in resistance, they merely reduce the power of datasets. Lastly, they
provide a tool for inferring the true extent of genetic variation in disease resistance given knowledge of the disease
biology.
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Introduction
Genetic variation in host resistance to infectious disease is
ubiquitous [1,2,3]. The increasing realization of this phenomenon
has led to disease biology becoming a major focus of ecology and
population or quantitative genetic research for human and animal
geneticists alike. Further, the ready availability of dense single
nucleotide polymorphism arrays (i.e. SNP chips) has given rise to
hitherto unforeseen opportunities to dissect this between-host
variation and identify possible genes contributing to this variation
using genome wide association studies [4]. This, coupled with
more traditional quantitative genetic variance-partitioning ap-
proaches [5], enables detailed descriptions of genetic aspects
of disease resistance and the identification of individuals with
extreme (high or low) risk of infection or disease [6]. Such
techniques can be applied equally to human, natural animal
populations or farmed livestock.
To have the requisite power to meaningfully quantify genetic
variation or perform a genome scan using a dense SNP chip it is
necessary to have datasets comprising observations on several
thousands of individuals [e.g. 7]. For studies of infectious diseases
this usually necessitates utilizing field data because challenge
experiments of a sufficient scale will not be possible, possibly
excepting studies with aquacultural species [e.g. 8]. For example,
in the livestock context, data may be captured from a population
undergoing an epidemic such as bovine tuberculosis [9], or from
an endemic disease such as mastitis [see 10], where the herd-level
prevalence is largely predictable. However, such field data is very
‘noisy’: diagnosis of infection or disease may be imprecise; it can be
difficult to determine when infection of an individual occurred;
and it is often unclear whether or not apparently healthy
individuals have been exposed to the infection. These factors will
add environmental noise to the epidemiological data.
Issues such as exposure and diagnostic test sensitivity or
specificity are fundamental concepts to epidemiologists when
studying the spread of disease in a population [11], yet their
intrinsic importance is currently ignored in quantitative genetic
theory [5]. Quantifying and accounting for the impact of
environmental factors is an integral part of identifying and
measuring true host genetic variation in resistance to the disease
under study. Consequently, there is an unrecognised risk of
biases in genetic parameter estimates and lost opportunities for
identifying individuals with extreme genetic risk. This paper
proposes advances in quantitative genetic theory using concepts
borrowed from epidemiology and provides predictive equations
for the impact of epidemiological factors on heritability estimation.
The theory is developed specifically for microparasitic infections,
such as those caused by viruses or bacteria.
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General Framework
Consider a generic microparasitic disease in which individuals
may move between infection states as illustrated in Figure 1. Upon
exposure to infection a susceptible (i.e. not yet infected) individual
may become infected and infectious, after which it may either
recover or die. For simplicity, the states of diseased and infectious are
considered equivalent in this study. The term susceptible does not
indicate an individual’s liability to infection; rather, it denotes that
it is not immunologically resistant and can become infected. If
susceptible individuals are replenished, either through loss of
immunity of recovered individuals or through immigration of new
individuals, then an endemic equilibrium may be reached in which
the expected disease prevalence is constant. Otherwise, under
assumptions of homogeneous random mixing the number of
infected individuals will ultimately go to zero, and the epidemic
will die out with the expected proportion of individuals ever
infected during the course of the epidemic (I*) satisfying the
equation I~1{e({R0I
) [12], where R0 is the basic reproductive
ratio of the disease. Therefore, assuming no disease-independent
mortality, the expected proportion of susceptible individuals
remaining in the population at the completion of the epidemic
is 1{I.
Inferences about host genetic resistance are generally made by
comparing diseased and healthy individuals. The diseased category will
include infected and/or dead individuals, and the healthy category
will include susceptible individuals, i.e. not yet infected, and possibly
recovered individuals. In more complex models, individuals with
latent infection that have yet to display detectable signs of infection
may also be included in the healthy category. Heritabilities are
determined by estimating to what degree the expected genetic
relationships predict the classification of individuals into healthy and
diseased, whereas individual SNP associations are inferred from
departures of SNP allele frequencies from their expectations within
the two categories. The genetic associations uncovered by such
analyses will indicate host genetic variation in ‘disease resistance’,
where the term ‘disease resistance’ is used generically to cover any
of the processes shown Figure 1 that may influence the probability
of an individual being diagnosed as diseased.
Several sources of uncertainty in field disease data can be
identified from Figure 1. Firstly, for an individual to move from
the susceptible to the latently infected or infectious category, it is
necessary for it to be exposed to infection. A lack of exposure
simply means that individuals do not have the opportunity to
express their genotype for resistance, with potentially highly
susceptible individuals being classified as healthy. In a group of
individuals one might quantify exposure by e, the probability that
an individual is exposed to infection. Secondly, the diagnostic test
used to classify individuals as healthy or diseased may be imperfect,
with individuals misclassified. Specificity (Sp) measures the
probability that a healthy individual is classified as healthy by the
diagnostic test, whereas sensitivity (Se) measures the probability
that a diseased individual is classified as diseased by the test [11].
Thirdly, it is apparent from Figure 1 that an epidemic is a dynamic
process. When data are collected over any time period which is less
than the duration of the epidemic, the outcomes may differ from
the outcomes that would have been obtained if the data were
to have been collected over the entire epidemic, again through
misclassifications.
These three phenomena whilst distinct are not independent, i.e.
they are interrelated outcomes of the properties of the epidemic. For
example, exposure probabilities may depend on the duration of data
recording, with the probability of exposure increasing with time.
However, for development of quantitative theory, their impacts are
described and interpreted separately. The impacts of incomplete
exposure and diagnostic test sensitivity and specificity can be
explored independent of the epidemic dynamics, and hence are
termed static disease properties. The impacts of time-dependent
measurements require dynamic disease epidemic models.
Static Disease Properties
(a) Incomplete Exposure to Infection. When there is
incomplete exposure to infection the observed prevalence, the
fraction of the whole population that is identified as diseased is a
function of two factors: (i) the proportion of individuals that have
been exposed to the pathogen (e), and (ii) the virtual prevalence (p),
which is defined as the proportion of individuals that have been
exposed to the pathogen that become infected. Assuming that
exposure is random and independent of host genotype, then the
observed prevalence is ep. Of the 1{ep proportion of individuals
that are healthy, e 1{pð Þ are exposed and apparently resistant,
whilst 1{eð Þ have not yet been exposed and have not expressed
any genotype related to ‘disease resistance’. The phenotypic
variance of observed ‘disease resistance’ is given by the binomial
variance ep 1{epð Þ.
Firstly, consider the epidemic among the exposed, with virtual
prevalence p. Suppose that on the underlying liability scale the
heritability is h2 for true disease resistance, i.e. resistance following
actual exposure, and the total liability has variance 1. Then using
the linear approximation often used in the genetic analyses of
binary traits [13], the genetic variance expressed on the binomial
0/1 scale is given by w xp
 2
h2 where xp is the truncation point of
the Normal distribution corresponding to upper-tail probability p,
and w xp
 
is the corresponding Normal density. Now consider the
case of incomplete exposure and let D9u and D9w be the observed
states (either healthy, 0, or diseased, 1) of individuals u and w with
numerator relationship auw, and let Z be an indicator trait with
Z~1 if both u and w are exposed and Z~0, otherwise. Assum-
ing exposure is independent of the numerator relationship then
cov D
0
u,D
0
wjZ~1
 
~auww xp
 2
h2 and cov D
0
u,D
0
wjZ~0
 
~0, so
cov D
0
u,D
0
wjZ
 
~auww xp
 2
h2Z; when Z=0 the covariance is not
expressed since at least one individual is not exposed, and there
is only one outcome for that individual, D9=0. Then using the
general formula for unconditional covariances: cov D
0
u,D
0
w
 
~
E cov D
0
u,D
0
wjZ
  
zcov E D
0
ujZ
 
,E D
0
wjZ
  
and noting (i) the
latter term is 0, and (ii) E Zð Þ~e2 the probability of both being
exposed, the result emerges: cov D
0
u,D
0
w
 
~auwe
2w xp
 2
h2.
Therefore on the 0/1 scale the true heritability of disease
resistance is w xp
 2
h2p{1 1{pð Þ{1 whilst the observed herita-
bility is ew xp
 2
h2p{1 1{epð Þ{1. This differs by a factor e 1{pð Þ=
1{epð Þ. This will always be #1 since both e#1 and 1{pð Þ=
1{epð Þƒ1. Furthermore, this biased heritability is transformed
back to the liability scale as kh2, where k~e2w xp
 2
=w xep
 2
. The
Figure 1. Model for transmission of bacterial or viral infections.
doi:10.1371/journal.pone.0008940.g001
Interpreting Disease Data
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8940
bias on the liability scale is less than that on the observed scale
since the reduced prevalence that is observed due to incomplete
exposure leads to a greater scaling of the observed heritability back
to the liability scale. For small ep, the under-prediction on the 0/1
scale is close to a linear function of e. The bias is greater if p is
moderate or large.
Impacts of differing exposure probabilities and differing virtual
prevalences are illustrated in Figures 2a and 2b where observed
and virtual prevalences are varied, respectively. In both cases the
exposure probability has a close to linear impact on the bias
parameter. The bias is more severe when considering the
relationship as a function of observed prevalence, because when
the exposure probability drops towards the observed prevalence, it
implies the healthy population is dominated by individuals that have
not been exposed to infection.
(b) Incomplete Sensitivity and Specificity of Diagnostic
Tests. Individuals will be classified into healthy and diseased
categories by means of a diagnostic test for the disease of interest.
Fundamental to any diagnostic test are the concepts of specificity
and sensitivity. As described above, specificity (Sp) is the probability
that a truly healthy individual is classified by the diagnostic test as
healthy and sensitivity (Se) is the probability that a truly diseased
individual is classified by the diagnostic test as diseased. The
implications of sensitivity and specificity on the proportions of
individuals diagnosed as healthy or diseased are shown in Table 1.
The true prevalence is given as p, and the prevalence observed
from the diagnostic test is p9.
Insight into the column margins can be gained by observing that
SpzSe{1
 
is the regression coefficient of the classification based
upon the diagnostic test on the true state where disease is scored 1 and
healthy 0. The regression line is D0~p0z SpzSe{1
 
D. As above,
let Du and Dw be the true classification of individuals u and w with
numerator relationship auw. The impact of imperfect Se and Sp on
estimates of heritability can be deduced assuming that the classifica-
tion errors are independent for u and w, and unrelated to Du or Dw.
The covariance between the observed classification D9u and D9w
can be obtained from cov D
0
u,D
0
w
 
~E cov D
0
u,D
0
wjDu,Dw
  
z
cov E D
0
ujDu,Dw
 
, E D
0
wjDu,Dw
  
. The first of these terms
is identically zero given the assumption made. The second
term is then the covariance of the terms in Table 2, which
can be derived from the regression line above. This gives
the result cov D
0
u,D
0
w
 
~ SpzSe{1
 2
cov Du,Dwð Þ. It then fol-
lows directly that if u and w have a genetic covariance of auwh
2
on the liability scale then cov Du,Dwð Þ~auww xp
 2
h2 and
cov D
0
u,D
0
w
 
~auww xp
 2
h2 SpzSe{1
 2
with observed preva-
lence p9. Thus, the observed heritability on the 0/1 scale is
h02~w xp
 2
h2 SpzSe{1
 2
p0{1 1{p0ð Þ{1 and when transformed
back to the liability scale it is w xp
 2
h2 SpzSe{1
 2
w xp0
 {2
.
Impacts of various specificities and sensitivities on estimated
heritability values are illustrated in Figures 3a and 3b, where only
sensitivity and specificity, respectively, are varied and 3c, in which
they are varied jointly. For all prevalences, imperfect sensitivity
and specificity both result in underestimated heritabilities on the
liability scale. However the impact of poor specificities is much
greater, for true prevalence less than 0.5. The reason for this
difference is that when decreasing Se, the term SpzSe{1
 
decreases, and the observed prevalence p9 decreases also, so
although SpzSe{1
 2v1, this is partially compensated by
w xp
 2
w xp0
 {2w1. In contrast, when Sp decreases, the observed
prevalence p9 increases, and so both SpzSe{1
 2v1 and
w xp
 2
w xp0
 {2v1. When both sensitivity and specificity are
imperfect, then liability-scale heritabilities are considerably under-
estimated. This is likely to be the case in many practical situations,
indicating that true genetic variation in disease resistance is likely to
be much greater than indicated by analyses of field data.
Figure 2. Ratio of estimated to true heritability on the liability
scale for incomplete exposure. Results are shown for (A) differing
observed prevalences or (B) differing virtual prevalences.
doi:10.1371/journal.pone.0008940.g002
Table 1. Proportions of individuals classified as Healthy or Diseased, as a function of Specificity (Sp) or Sensitivity (Se).
Classification by diagnostic test:
Healthy Diseased Total
True State: Healthy 1{pð ÞSp 1{pð Þ 1{Sp
 
1{p
Diseased p 1{Seð Þ pSe p
Total 1{p0~Sp{p SpzSe{1
 
p0~ 1{Sp
 
zp SpzSe{1
 
doi:10.1371/journal.pone.0008940.t001
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Dynamic Disease Properties
The principle of dynamic epidemic models is that individuals
move between infection state categories, as shown in Figure 1. At
different points during the epidemic it may be different individuals
that are observably diseased, and the efficiency with which all
potentially diseased individuals (I*) are observed as diseased depends
on the duration of the data collection period in relation to the
dynamics of the epidemic. In most data recording scenarios lasting
for a time period Dt, i.e. temporally incomplete data recording,
only a proportion of individuals ever transiting through the
infectious/diseased categories will be observed. Let the total number
of individuals observed to be infectious/diseased in the interval t to
tzDt be defined as I t,Dtð Þ therefore the proportion of all
individuals ever diseased that are observed is I t,Dtð Þ=I. This is
analogous to imperfect diagnostic test sensitivity. Therefore, the
impact of temporally incomplete data recording on estimated
heritabilities is the same as for imperfect sensitivity.
As an illustration of the impact of dynamic disease properties,
consider a simple SIR model [12]. Let S(u) and I(u) be the
instantaneous number of susceptible and infectious animals at time
u, and b be the transmission coefficient for the disease. For a
recording period starting at time u = t, and lasting for time period
Dt, then I t,Dtð Þ~I tð Þz Ð
tzDt
t
bS uð ÞI uð Þdu. Therefore, the ratio
I t,Dtð Þ=I will depend not only on the duration of the recording
period Dt, but also when recording commenced in relation to the
epidemic. This ratio will be termed the ‘epidemic sensitivity’.
As an illustration, consider an SIR model with parameters
b=0.00015, c=0.1, where c is the recovery rate, R0=1.5 and
hence I*=0.59. For this parameterization, and starting with one
infected individual, it will take approximately 180 days for 95% of
all individuals potentially infected during an epidemic to become
diseased. It is assumed that recording starts when the disease
prevalence reaches 5% and that the diagnostic test is perfect, i.e.
sensitivity and specificity are both unity. Two scenarios are
considered, (i) where only infectious/diseased individuals are
observed, and (ii) where recovered/removed, e.g. dead, individuals
are also observed. Plotted in Figure 4 are the proportions of
individuals ever diseased during the course of the epidemic that are
observed during the observation period, i.e. the epidemic
sensitivity I t,Dtð Þ=I. Observations taken only at one time point
will result in a low epidemic sensitivity, hence underestimated
heritabilities, and observations taken at different start points will
also vary. If both diseased and recovered/removed individuals are
observable, then the epidemic sensitivity becomes high with an
extended observation period, since individuals that are infected
and recover or removed prior to recording are also observed.
However, if recovered individuals are not observable, i.e. they are
healthy and no longer show any symptoms or clinical signs, then
the epidemic sensitivity remains low and heritabilities remain
underestimated.
Discussion
This paper has provided a framework to assist in the
interpretation of field disease data, with extensions to quantitative
genetics theory being presented to account for the effects of various
forms of environmental noise on genetic parameters for disease
resistance. The factors considered, viz. incomplete recording,
incomplete exposure, imperfect sensitivity and specificity of
diagnosis are all typical of the non-genetic influences encountered
with field disease data. We demonstrate in this paper that the likely
impacts of these factors on genetic parameters for disease
resistance are largely predictable, provided ball park figures can
be obtained for specificity, sensitivity or exposure probabilities. In
summary, estimable heritabilities are biased downwards by each of
these factors. Conversely, the presence of detectable genetic
variation in field disease data implies that the true heritability for
disease resistance, were it to be measured under ideal circum-
stances, is likely to be much higher.
A further significance of the theory presented in this paper is
that it can reconcile our observation that whilst traits describ-
ing immune responses to infection are often highly heritable,
the disease outcomes that these traits influence tend to be lowly
Table 2. Covariance expectations between animals with
different disease classification status.
Du Dw Probability E D
0
ujDu,Dw
 
E D
0
wjDu,Dw
 
1 1 p2zcov Du,Dwð Þ Se Se
1 0 p 1{pð Þ{cov Du,Dwð Þ Se 1{Sp
0 1 1{pð Þp{cov Du,Dwð Þ 1{Sp Se
0 0 1{pð Þ2zcov Du,Dwð Þ 1{Sp 1{Sp
doi:10.1371/journal.pone.0008940.t002
Figure 3. Ratio of estimated to true heritability on the liability scale for differing true prevalences. Results are shown for (A) incomplete
sensitivity, where specificity = 1, (B) incomplete specificity, where sensitivity = 1 or (C) for incomplete specificity and sensitivity, where the two
parameters equal.
doi:10.1371/journal.pone.0008940.g003
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heritable. This is best illustrated from extensive datasets collected
in farmed livestock. For example, components of innate and
adaptive immunity are often moderately to highly heritable in
commercial pig populations [14,15], whereas the heritability of
observable disease in such animals is low to moderate at best
[16,17]. Whilst true presence or absence of disease, given exposure
to infection, will be largely a function of the immune response, we
have demonstrated that the actual prevalence of disease and the
estimable genetic variation between animals will be influenced by
variable exposure and the sensitivity of diagnosis. Similarly, in
commercial dairy cattle, many studies have demonstrated that the
occurrence of clinical mastitis invariably has a heritability less
than 0.1 [10], whereas underlying immune responses to infec-
tion display heritabilities which though variable are often high
[e.g. 18].
Published field data are available which supports the concepts
developed in this paper. For example, predicted impacts of
exposure to infection on estimable heritabilities may be inferred
from data recently published on resistance to infectious pancreatic
necrosis (IPN), a viral disease affecting farmed salmon. Heritabil-
ities for IPN-related survival of salmon located in seawater
localities containing the IPN virus were estimated and presented
for seven independent cohorts of fish [19]. Of these seven cohorts,
five fulfilled criteria of comprising populations unselected for IPN
resistance and having heritability values consistent with the
observed prevalence, i.e. heritabilities transformed to the liability
scale [13] remained within the parameter space. For these five
cohorts, the observed prevalences were 0.10, 0.12, 0.14, 0.19 and
0.30 and the corresponding heritabilities on the observed (0,1)
scale were 0.11, 0.20, 0.16, 0.28 and 0.56, respectively, showing
the expected strong relationship between prevalence and herita-
bility for this scale. In principle, transformation to the liability scale
should remove the relationship between prevalence and heritabil-
ity, but the values obtained (0.32, 0.53, 0.39, 0.59 and 0.97)
continue to show a significant linear relationship with prevalence.
Because these five cohorts may be regarded as subpopulations
sampled at random in relation to IPN resistance from the same
overall population, it may be hypothesized that the differences in
prevalence simply reflect differences in exposure rates. Relative
exposure probabilities in each cohort may therefore be estimated
as the ratio of observed prevalence to that seen in the cohort
with the highest prevalence. Estimating exposure probability in
this way, and using the above theory to rescale the heritability for
liability, resulted in the heritabilities displayed in Figure 5, along
with the regression of these heritabilities on observed prevalence.
The strong linear relationship between prevalence and the
heritability of liability to IPN disappeared when differences in
relative exposure probabilities were hypothesized and the induced
biases were removed. Furthermore it suggests that the heritability
is large and important.
The heritability of resistance to bovine tuberculosis in dairy
cattle provides an example of the potential impact of diagnostic
test sensitivity and specificity on observable genetic variation. A
recent publication provided convincing evidence of moderate
genetic variation in tuberculosis resistance in dairy cattle, with an
average heritability of liability of 0.12 in a dataset with a
prevalence of 0.10 [9]; further, this paper speculated that
imperfect sensitivity and specificity may have resulted in an
underestimation of the true heritability. At this prevalence,
imperfect specificity has a large impact on the estimated
heritability, however the specificity of this diagnostic test is likely
to be high. Sensitivity may be lower, possibly closer to 0.8 [20].
Exploring scenarios for specificities of 0.98 or 0.99, and
sensitivities varying between 0.7 and 0.9, leads to the conclusion
that the observed heritability is possibly underestimated by 20 to
40%. Therefore, the true heritability in this population is likely to
be in the range 0.15 to 0.20.
Sometimes, particularly in an animal breeding context, an
indicator trait is used to describe the impact of infection or disease
upon an individual, for example somatic cell count in the milk of
lactating ruminants with mastitis [10]. Hence, the measurements
comprise a mixture distribution, i.e. those taken on both healthy
and diseased individuals. These data may be analysed ignoring the
fact that some individuals are healthy and others diseased, however
this potentially leads to misleading results if the statistical pro-
perties of the trait (variance, heritability, etc) differ between the
two subpopulations, or if the biological interpretation of the
indicator trait differs between the two subpopulations. For
example, dairy cattle breeders may wish to select on somatic cell
count to reduce the incidence of mastitis, but they may not wish to
alter mean somatic cell count in healthy cows [10]. Ideally, the data
could be split into healthy and diseased subpopulations, and analysed
separately. Various methods based on the properties of the data
distribution have been proposed to achieve this [21]; alternatively
an independent diagnostic of infection may be used, such as the
presence of mastitis-causing microorganisms in the milk. Whatever
approach is used, the concepts of diagnostic test accuracy still
apply and biases may occur if these are ignored. For example the
Figure 4. An example of the proportion of individuals recorded
as infectious/diseased relative to those ever infectious/diseased
during an SIR epidemic, as a function of recording period. Two
cases are shown, with only I individuals observable or with both I and R
observable. In this example, recording is triggered when prevalence
reaches 5%. Parameters in this model are: b= 0.00015, c=0.1 and
R0= 1.5.
doi:10.1371/journal.pone.0008940.g004
Figure 5. Heritabilities for liability to death from infectious
pancreatic necrosis in five cohorts of Atlantic salmon, before
and after correction for inferred relative exposure levels. The
data are from Guy et al. 2009 [19]. Shown are heritability values and
linear regression trend lines.
doi:10.1371/journal.pone.0008940.g005
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true difference in the indicator trait between the subpopulations
will be underestimated for imperfect sensitivity or specificity, as
animals will be misclassified.
We now determine the impact of imperfect sensitivity and
specificity on the properties of indicator traits such as somatic cell
count. If Hi and Di are indicator trait observations in truly healthy or
diseased subpopulations, and H9i and D9i are indicator trait
observations in an imperfectly classified population in which the
observed prevalence is p9, then the estimated true difference between
diseased and healthy individuals D~mD{mHð Þ is, after simplifi-
cation, D~ mD0{mH 0ð Þ SpzSe{1
 
p 1{pð Þ= p0 1{p0ð Þ½  {1. For
plausible Sp and Se values, D is always greater than mD0{mH 0ð Þ.
Similarly, properties of the variances of the observed subpopulations
can be estimated from the properties of mixture distributions, and
they contain an upwards bias proportional to D2. We have applied
these concepts to mastitis in sheep (Riggio, Bishop and coworkers,
unpublished data), using a dataset where diagnoses were available for
the mastitis infection status of every ewe on every occasion that
somatic cell count measurements were taken. These data demon-
strated that specificity and sensitivity of diagnosis must have been
high, as poor values would have led to implausible D values. Given
high but plausible specificity and sensitivity (.0.9), inferred genetic
correlations between the indicator trait measured in healthy and
diseased animals were moderate (ca. 0.6) and insensitive to small
changes in either parameter.
The theory presented in this paper does contain a number of
simplifying assumptions, most notably that exposure probability or
diagnostic test sensitivity and specificity are independent of host
genotype. These assumptions may sometimes be violated. As an
example, related individuals may be more likely to be co-exposed to
infection, e.g. family members in the same household or animals in
the same litter, and this potentially introduces a bias into heritability
estimation. An issue may also arise with diagnostic tests in which
animal immune responses are measured, such as skin test measure-
ments used to infer exposure to bovine tuberculosis [20]. If aspects of
these immune responses are genetic in origin, as seems plausible, this
may impact on diagnostic test sensitivity. We have yet to fully explore
the impact of these factors on expected genetic parameter values.
Many disease genetic studies now bypass the step of estimating
variance components to quantify genetic variation and move
directly to SNP association studies, unfortunately ignoring the
design information that may give an objective assessment of the
plausibility of both the design and the outcomes of the study.
Nevertheless, the principles and consequences of noisy field data
for the estimation of SNP effects are analogous to those for
variance component estimation. For example, with incomplete
exposure a fraction 1{eð Þ= 1{epð Þ of individuals that are healthy
have not been exposed and hence do not contribute information.
Therefore, the effective size of the control population is smaller by
this proportion. Furthermore, with imperfect sensitivity and
specificity, there is a reduction in the estimable SNP effect size
by SpzSe{1
 
due to the regression coefficient of the diagnostic
classification on the true state, with a consequent reduction in the
experimental power for detecting SNP associations.
In summary, we believe that the results presented in this paper
add clarity to the interpretation of field disease data, and reduce
the risk that incorrect inferences are made regarding the extent of
genetic variation. We have considered the different aspects of field
data separately, but the underlying theory is clear and the
potential exists to combine the different factors to match specific
scenarios. We suggest that published estimates of heritabilities for
resistance to microparasitic diseases, corresponding SNP effects
and study design should be re-appraised given knowledge of the
disease biology, i.e. likely exposure to infection, properties of the
diagnostic tests and duration of data recording.
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